BCM
SNY icon

BlueCrest Capital Management’s Sanofi SNY Stock Holding History

BlueCrest Capital Management’s Portfolio SNY Stock Details SNY Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2016
Q2 		– Sell
-15,000
Closed -$602K – 1027
2016
Q1 		$602K Buy
+15,000
New +$603K 0.04% 471

Other funds holding SNY

Dodge & Cox
Dodge & Cox San Francisco, California $182B AUM 14.68% 1-Year Est. Return
Fisher Asset Management
Fisher Asset Management Camas, Washington $295B AUM 31.6% 1-Year Est. Return
Barrow, Hanley, Mewhinney & Strauss
Barrow, Hanley, Mewhinney & Strauss Dallas, Texas $30.5B AUM 29.95% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
Invesco
Invesco Atlanta, Georgia $1.02T AUM 30.18% 1-Year Est. Return
Bank of America
Bank of America Charlotte, North Carolina $1.37T AUM 24.88% 1-Year Est. Return
Hotchkis & Wiley Capital Management
Hotchkis & Wiley Capital Management Los Angeles, California $32.4B AUM 17.21% 1-Year Est. Return
Macquarie Group
Macquarie Group Sydney, NSW 2000, Australia $16.8B AUM 27.39% 1-Year Est. Return
Lazard Asset Management
Lazard Asset Management New York $60.8B AUM 22.47% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return

BlueCrest Capital Management's SNY Position: Q2 2019 in Review

BlueCrest Capital Management sold out of Sanofi (SNY) in Q2 2019, closing a stake of 5,558 shares — an estimated $246K sold.

BlueCrest Capital Management first reported a position in SNY in Q4 2016 and held it in 3 quarters. The position peaked at $348K in Q4 2016. 482 funds tracked by Wall St. Rank hold SNY as of Q2 2019.

  • BlueCrest Capital Management reported no remaining Sanofi position as of Q2 2019 after selling out during the quarter.
  • BlueCrest Capital Management sold 5,558 Sanofi shares in Q2 2019, an estimated $246K.
  • BlueCrest Capital Management first reported a position in Sanofi in Q4 2016 and held it in 3 quarters.
  • BlueCrest Capital Management's Sanofi position peaked at $348K in Q4 2016.
  • 482 funds tracked by Wall St. Rank held Sanofi as of Q2 2019.

Based on BlueCrest Capital Management's 13F filing for Q2 2019, filed 14 Aug 2019.